RIVERA TERÁN, V. et al. 2025. OVERLIFE OF BIOLOGIC AND SYNTHETIC TARGETED DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE LATIN AMERICAN COUNTRIES. Investigación en Discapacidad. 11, S1 (Nov. 2025).